ArticleMedical oncology (Northwood, London, England)2014

LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy.

Yue Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.